Conceptual image of hands piecing together plain pieces of jigsaw

ELPIS study

Conceptual image of hands piecing together plain pieces of jigsaw

Optimising dEcision-making and support for famiLies of PatIentS who have life-sustaining treatments withheld/withdrawn in adult intensive care units

In intensive care units (ICUs), patient deaths often occur after decisions to limit life-sustaining treatments. This may happen when a patient deteriorates and does not show any signs of recovery, and involves shared decision-making between families and clinicians regarding limiting or stopping interventions. Since many patients haven't expressed their preferences, families are expected to advocate on their behalf. However, this decision-making and witnessing the dying process can have an impact on family members that may lead to psychological distress and short or long-term negative emotions. There is limited research on how family members experience end-of-life decision-making and the patient’s dying process in United Kingdom ICUs and what may be perceived as compassionate care during this time.

This study aimed to develop a theoretically driven experience-based model of care to support family members’ end-of-life decision-making and improve practices associated with withholding/withdrawing life-sustaining treatments in adult ICUs.

How the ELPIS study was carried out

The study was carried out in the West Midlands, UK, a region with a diverse population and higher‑than‑average levels of illness and premature death. Families who have lived through the death of a relative in ICU were at the centre of the research.

ELPIS used a three‑phase qualitative research design. In the first two phases, we conducted in‑depth interviews with 25 bereaved family members whose relatives had died in an adult ICU following the withdrawal or withholding of life‑sustaining treatment. These interviews explored families’ experiences of communication, decision‑making, care during dying, and support after death.

The findings from these interviews were analysed using a structured, step‑by‑step method that allowed patterns and themes to emerge directly from participants’ accounts. This approach ensured that the results were firmly grounded in real experiences rather than preconceived assumptions.

In the third phase, we held an online co‑production workshop involving bereaved family members, ICU survivors, patient and public involvement (PPI) contributors, and ICU clinicians. Participants reviewed the developing model, shared reflections, and helped refine recommendations to make them realistic and usable in everyday clinical practice.

What we found

Families’ experiences clustered into four connected stages that together form the ELPIS Care Model.

  1. Early recognition and preparation
    Many families arrived in ICU unprepared for how unwell their relative was. Clear, honest, and compassionate communication early in the ICU stay helped families understand what was happening and reduced shock and confusion later. When clinicians avoided difficult conversations or provided overly optimistic reassurance, families reported mistrust and found it harder to process events and grieve after the death. Knowing a patient’s previously expressed wishes, where these were available, made families feel more confident and less anxious.

  2. Shared decision‑making about life‑sustaining treatment
    Families wanted to be involved in decisions, but most did not want to feel solely responsible. The best experiences occurred when clinicians offered a clear medical recommendation, explained it carefully, and guided families through decisions over time. Problems arose when responsibility felt transferred entirely to families or when discussions were rushed or poorly explained. Families needed time to absorb information, balance hope and reality, and reach a sense of readiness.

  3. Care during withdrawal of treatment
    How care was delivered during the final hours mattered deeply. Privacy, flexible visiting, and being able to remain with a loved one were seen as essential to dignity. Families were reassured when they could see that comfort, pain relief, and symptom control remained a priority. In contrast, unmanaged symptoms, lack of privacy, or restricted access caused lasting distress and shaped negative memories of the death.

  4. Care after death and during bereavement
    What happened after death was just as important as what happened before. Families valued time with their relative, sensitive preparation of the body, respectful handling of belongings, and meaningful mementoes when offered appropriately. Many participants, however, reported little or no information about bereavement support and struggled to access help later. This lack of follow‑up left some families to cope with prolonged or complicated grief alone.

The ELPIS Care Model

Drawing together all phases of the study, we developed the ELPIS Care Model, a four‑phase supportive care framework covering:

  1. Early recognition and preparation
  2. Shared decision‑making
  3. Active supportive care during treatment withdrawal
  4. Care after death and bereavement

The model describes key practices needed at each stage, who should be involved, and the risks when support is missing. Importantly, it views bereavement care as an integral part of end‑of‑life care, not an optional add‑on.

Why this matters

The ELPIS study provides new, UK‑based evidence on how ICU teams can better support families facing the withdrawal or withholding of life‑sustaining treatment. By grounding recommendations in lived experience and refining them with patients, families, and clinicians, the ELPIS Care Model offers practical guidance to improve care, reduce long‑term distress for families, and support decision‑making that is compassionate, clear, and shared.

Future work will focus on testing and implementing the model in practice to assess its impact across different ICU settings.

Funded by:

This study/project was funded by the National Institute for Health and Care Research (NIHR) [Research for Patient Benefit (NIHR206331)]. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

Who are the research team?

The research team is made up by academics and researchers working at the University of Birmingham with experience in qualitative end-of-life research, ICU clinicians who work at Sandwell and West Birmingham Hospitals NHS Trust, and a member of the public. A research fellow is also supporting the research team.

Research team members:

Project dates

June 2024 - March 2026

Enquiries

Dr Nikolaos Efstathiou (Project Lead)
Email: n.efstathiou@bham.ac.uk

Dr Sepideh Setayesh (Clinical Research Fellow)
Email: s.setayesh@bham.ac.uk